אולנזאפין דקסל 5 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

OLANZAPINE 5 MG

Verfügbar ab:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-Code:

N05AH03

Darreichungsform:

TABLETS

Verabreichungsweg:

PER OS

Hergestellt von:

DEXCEL LTD

Therapiegruppe:

OLANZAPINE

Anwendungsgebiete:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Berechtigungsdatum:

2012-05-01